Janus Henderson Group’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$202K Hold
24,922
﹤0.01% 2329
2025
Q4
$259K Hold
24,922
﹤0.01% 2267
2025
Q3
$221K Sell
24,922
-561,909
-96% -$4.01M ﹤0.01% 2306
2025
Q2
$3.39M Buy
586,831
+561,909
+2,255% +$3.44M ﹤0.01% 1053
2025
Q1
$176K Hold
24,922
﹤0.01% 2395
2024
Q4
$217K Hold
24,922
﹤0.01% 2399
2024
Q3
$487K Hold
24,922
﹤0.01% 2047
2024
Q2
$513K Sell
24,922
-341
-1% -$7.01K ﹤0.01% 1978
2024
Q1
$538K Buy
25,263
+2
+0% +$39 ﹤0.01% 1972
2023
Q4
$364K Sell
25,261
-74
-0.3% -$728 ﹤0.01% 2140
2023
Q3
$231K Buy
25,335
+39
+0.2% +$396 ﹤0.01% 2314
2023
Q2
$267K Sell
25,296
-43
-0.2% -$509 ﹤0.01% 2313
2023
Q1
$310K Buy
25,339
+13,851
+121% +$173K ﹤0.01% 2268
2022
Q4
$142K Hold
11,488
﹤0.01% 2266
2022
Q3
$157K Buy
11,488
+19
+0.2% +$293 ﹤0.01% 1954
2022
Q2
$210K Sell
11,469
-15
-0.1% -$216 ﹤0.01% 2280
2022
Q1
$185K Buy
11,484
+2
+0% +$29 ﹤0.01% 2460
2021
Q4
$161K Buy
+11,482
New +$186K ﹤0.01% 2447
2021
Q1
Sell
-86,038
Closed -$2.81M 1599
2020
Q4
$2.81M Buy
+86,038
New +$3.02M ﹤0.01% 1076

Other funds holding KURA

Janus Henderson Group's KURA Position: Q1 2026 in Review

Janus Henderson Group held its Kura Oncology (KURA) position steady in Q1 2026 at 24,922 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #2329.

Janus Henderson Group first reported a position in KURA in Q4 2020 and has held it in 19 quarters since. The position peaked at $3.39M in Q2 2025. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Janus Henderson Group held 24,922 shares of Kura Oncology worth $202K as of Q1 2026.
  • Janus Henderson Group left its Kura Oncology share count unchanged in Q1 2026.
  • Kura Oncology made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2329 holding.
  • Janus Henderson Group first reported a position in Kura Oncology in Q4 2020 and has held it in 19 quarters since.
  • Janus Henderson Group's Kura Oncology position peaked at $3.39M in Q2 2025.
  • 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.